Minocycline/Adapalene

米诺环素/阿达帕林

Report date: 2026/03/04 20:01:44

Base Information

Drug NameMinocycline/Adapalene
Drug Alias Nameminocycline + adapalene ( Menlo Therapeutics)FCD-105
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Tetracycline antibiotics
Mechanisms of Action30S ribosomal subunit inhibitorsRetinoic acid receptor gamma agonistsRetinoic acid receptor beta agonists +[4] 
Targets30S ribosomal subunitRetinoic acid receptor gammaRetinoic acid receptor beta +[4] 
Therapy Area/IndicationsAcne Vulgaris
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes Minocycline HydrochlorideAdapalene
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMenlo Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJourney Medical CorpVyne Therapeutics IncCutia Therapeutics (Shanghai) Co Ltd
Active IndicationsN/A
Inactive IndicationsAcne Vulgaris

Other Information

ATC CodeN/A
Related LinksN/A